Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115650) titled 'Evaluating Engineered Lactobacillus reuteri with a Zinc Sulfate-Tannic Acid MPN Coating for Acne: A Double-Blind, Randomized Controlled Trial' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shenzhen People's Hospital
Condition:
Acne
Intervention:
Control Group :Apply the Lactobacillus reuteri cream to the acne lesions once daily for 2 weeks.
Experimental Group:Apply the MPN-coated engineered Lactobacillus reuteri cream to the acne lesions once daily for 2 weeks.
Positive Control Group:Apply 0.1% tretinoin cream to the acne lesions once daily for 2 weeks.
Recruit...